Liver Transplant and Combined Liver-Kidney Transplant
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 198 alerts
Get alerted when Policy 198 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity, investigational status, exclusions, coding, and prior authorization for liver transplantation, liver retransplantation, and combined liver-kidney transplantation for adult and pediatric commercial members. It applies to managed care, PPO, and indemnity products.
The February 2026 policy update classified unresectable colorectal liver metastases, hepatic epithelioid hemangioendothelioma, hepatic adenomas, and intrahepatic cholangiocarcinoma as investigational indications for liver transplantation and clarified that the policy applies to adults and children.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.